$CDXC News Article - ChromaDex Shares Findings fro
Post# of 46
(Total Views: 188)
Posted On: 03/02/2022 11:15:53 AM
$CDXC News Article - ChromaDex Shares Findings from First-Ever Peer-Reviewed Published Clinical Study Analyzing the Promising Effect of Nicotinamide Riboside (NR) Supplementation in Patients with Parkinson's Disease (PD) https://marketwirenews.com/news-releases/chro...41284.html
(0)
(0)Chromadex Corp (CDXC) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼